2-Methyl-1-(piperazin-1-yl)propan-2-ol dihydrochloride

Catalog No. :
ACLRJE687
CAS No. :
1044707-11-0
Molecular Formula :
C8H20Cl2N2O
Molecular Weight :
231.17

IUPAC Name:2-methyl-1-(piperazin-1-yl)propan-2-ol dihydrochloride

2-Methyl-1-(piperazin-1-yl)propan-2-ol dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$60.00Login to see priceIn stockInquiry
250mg97%$98.00Login to see priceIn stockInquiry
1g97%$266.00Login to see priceIn stockInquiry
5g97%$1065.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-1-(piperazin-1-yl)propan-2-ol dihydrochloride
IUPAC Name2-methyl-1-(piperazin-1-yl)propan-2-ol dihydrochloride
MDL No.MFCD26400086
Molecular FormulaC8H20Cl2N2O
Molecular Weight231.17
SMILESCC(O)(C)CN1CCNCC1.[H]Cl.[H]Cl
InChI KeyIIJUXICBRWEDLY-UHFFFAOYSA-N
Synonym2-Methyl-1-(piperazin-1-yl)propan-2-ol dihydrochloride;EOS-62426;2-Methyl-1-(1-piperazinyl)-2-propanol Dihydrochloride
CAS No.1044707-11-0
PubChem CID66728465

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H303-H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLRJE687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUEOA094 route compound structure diagram
    ACUEOA0941267341-14-9 In Stock
  2. Then
  3. ACLRJE687 route product structure diagram
    ACLRJE6871044707-11-0 In Stock
Inquiry

2. ACLRJE687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLRJE687 route product structure diagram
    ACLRJE6871044707-11-0 In Stock
Inquiry

Comments (0)